Monitoring approved catheter devices during heart rhythm ablation
Part of Heart & circulation clinical trials.
This study is observing people with common abnormal heart rhythms who are already scheduled for a catheter ablation using an approved Biosense Webster catheter. It aims to better understand real-world use and outcomes, without testing a new drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation (AF) or supraventricular tachycardia (SVT) or ventricular tachycardia (VT)
- Your doctor has you scheduled for a catheter ablation using the specific approved Biosense Webster therapeutic catheter
- You can follow the hospital’s routine pre-, post-, and follow-up testing visits
- You sign the informed consent form if required by local rules
- You are not currently enrolled in another interventional drug or device trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based treatment for people with certain types of very fast or extra heartbeats that come from the lower chambers of the heart. The catheter uses a special energy to stop the abnormal beats and might help if you have had symptoms despite other treatments.
This study tests a new imaging technique to help guide heart ablation procedures for certain heart rhythm problems. It may help doctors see exactly where to treat.
This study looks at how well catheter ablation works for treating certain heart rhythm disorders (like atrial fibrillation or ventricular arrhythmias) using a specific brand of catheters. The aim is to gather real-world data to better understand the procedure's outcomes.
This trial tests a new catheter that can measure tissue temperature during ablation for rapid heartbeats like supraventricular tachycardia and atrial fibrillation. It aims to see if it is safe and effective.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Arrhythmias, Cardiac trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.